Enterostatin inhibition of dietary fat intake is dependent on CCK-A receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Lin, Ling ^a   Thomas, Sonjya R ^a   Kilroy, Gail ^a   Schwartz, Gary J ^b   York, David A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cholecystokinin A receptor; Intracerebroventricular; Lorglumide; Near celiac arterial

Indexed keywords

BETA CASOMORPHINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; ENTEROSTATIN; GASTROINTESTINAL HORMONE; LORGLUMIDE; PENTAPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CELIAC ARTERY; CELL STRAIN 3T3; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; GASTROINTESTINAL TRACT; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; LIPID DIET; LOW FAT DIET; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; SENSORY NERVE; VAGUS NERVE;

EID: 0041307390     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00147.2003     Document Type: Article

References (48)

1. Avery DD and Livosky M. Peripheral injections of bombesin and cholecystokinin affect dietary self-selection in rats. Pharmacol Biochem Behav 25: 7-11, 1986.
2. Branchereau P, Bohme GA, Champagnat J, Morin-Surun MP, Durieux C, Blanchard JC, Roques BP, and Denavit-Saubie M. Cholecystokinin A and cholecystokinin B receptors in neurons of the brain stem complex of the rat: pharmacological identification. J Pharmacol Exp Ther 260: 1433-1440, 1992.
3. Calingasan NS, Ritter R, Ritter S, and Brenner L. Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. Am J Physiol Regul Integr Comp Physiol 263: R572-R577, 1992.
4. Corp ES, McQuade J, Moran TH, and Smith GP. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res 24: 161-166, 1993.
5. Covasa M and Ritter RC. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22: 1339-1348, 2001.
6. Day HE, McNight AT, Poat JA, and Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33: 719-727, 1994.
7. Erlanson-Albertsson C, Mei J, Okada S, York DA, and Bray GA. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav 49: 1191-1194, 1991.
8. Froetschel MA, Azain MJ, Edwards GL, Barb CL, and Amos HE. Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats. J Nutr 131: 3270-3276, 2001.
9. Funakoshi A, Miyasaka K, Shinozaki H, Masuda M, Kawanami T, Takata Y, and Kono A. An animal model of congenital defect of gene expression of chylocystokinin (CCK)-A receptor. Biochem Biophys Res Commun 210: 787-796, 1995.
10. Gilbertson TA, Liu l York DA, and Bray GA. Dietary fat preferences are inversely correlated with peripheral gustatory fatty acid sensitivity. Ann NY Acad Sci 855: 165-168, 1998.
11. Greenberg D, Torres NI, Smith GP, and Gibbs J. The satiating effects of fats is attenuated by the chylocystokinin antagonist lorglumide. Ann NY Acad Sci 575: 517-520, 1989.
12. Lin L, Bray GA, and York DA. Enterostatin suppresses food intake in rats after near celiac and intracarotid arterial injection. Am J Physiol Regul Integr Comp Physiol 278: R1346-R1351, 2000.
13. Lin L, Braymer HD, and York DA. Procolipase gene and enterostatin expression in the rat brain (Abstract). FASEB J A783, 2002.
14. Lin L, Chen J, and York DA. Chronic icv enterostatin preferentially reduced fat intake and lowered body weight. Peptides 18: 657-661, 1997.
15. Lin L, Okada S, York DA, and Bray GA. Structural requirements for the biological activity of enterostatin. Peptides 15: 849-854, 1994.
16. Lin L, Umahara M, York DA, and Bray GA. β-Casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 19: 325-331, 1998.
17. Lin L and York DA. Enterostatin actions in the amygdala and PVN to suppress feeding in the rat. Peptides 18: 1341-1347, 1997.
18. Lin L and York DA. Comparisons of the effects of enterostatin on food intake and gastric emptying in rats. Brain Res 745: 205-209, 1997.
19. Lin L and York DA. 5-HT 1b antagonist in the PVN blocks the feeding response to enterostatin in the amygdala. Obes Res 9: S56, 2001.
20. Lin L and York DA. Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. Am J Physiol Regul Integr Comp Physiol 275: R619-R623, 1998.
21. Lin L and York DA. Changes in the microstructure of feeding after administration of enterostatin into the paraventricular nucleus and the amygdala. Peptides 19: 557-562, 1998.
22. Matson CA, Reid DF, Cannon TA, and Ritter RC. Cholecystokinin and leptin act synergistically to reduce body weight. Am J Physiol Regul Integr Comp Physiol 278: R882-R890, 2000.
23. Mei J, Bowyer RC, Jehanli AMT, Patel G, and Erlanson-Albertsson C. Identification of enterostatin, the pancreatic pro-colipase activation peptide, in the intestine of rat: effect of CCK-8 and high fat feeding. Pancreas 8: 488-493, 1993.
24. Mei J and Erlanson-Albertsson C. Role of duodenally administered enterostatin in the rat: inhibition of food intake. Obes Res 4: 161-165, 1996.
25. Melville LD, Smith GP, and Gibbs J. Devazipide antagonizes the inhibitory effect of cholecystokinin on intake in sham feeding rats. Pharmacol Biochem Behav 43: 975-977, 1992.
26. Mercer LD and Beart PM. Histochemistry in rat brain and spinal chord with an antibody directed at the cholecystokinin A receptor. Neurosci Lett 225: 97-100, 1997.
27. Okada S, York DA, Bray GA, and Erlanson-Albertsson C. Enterostatin (VAL-PRO-ASP-PRO-ARG), the activation peptide of procolipase selectively reduces fat intake. Physiol Behav 49: 1185-1189, 1991.
28. Okada S, York DA, Bray GA, Mei J, and Erlanson-Albertsson C. Differential inhibition of fat intake in two strains of rat by the peptide enterostatin. Am J Physiol Regul Integr Comp Physiol 262: R1111-R1116, 1992.
29. Okada S, York DA, and Bray GA. Procolipase mRNA: tissue localization and effects of diet and adrenalectomy. Biochem J 292: 787-789, 1993.
30. Ookuma K, Barton C, York DA, and Bray GA. Effect of enterostatin and kappa-opioids on macronutrient selection and consumption. Peptides 18: 785-791, 1997.
31. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic, 1982.
32. Reidy CA, Chavez M, Figlewiez DP, and Woods SC. Central insulin enhances sensitivity to cholecystokinin. Physiol Behav 58: 755-760, 1995.
33. Ritter RC, Brenner LA, and Tamura CS. Endogenous CCK and the peripheral neural substrates of intestinal satiety. Ann NY Acad Sci 713: 255-267, 1994.
34. Ritter S and Taylor JS. Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats. Am J Physiol Regul Integr Comp Physiol 256: R1232-R1239, 1989.
35. Schwartz GJ and Moran TH. Integrative gastrointestinal actions of the brain-gut peptide cholecystokinin in satiety. Prog Psychobiol Physiol Psychol 17: 1-34, 1998.
36. Schwartz GJ, Whitney A, Skoglund C, Castonguay TW, and Moran TH. Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol Regul Integr Comp Physiol 277: R1144-R1151, 1999.
37. Smith BK, York DA, and Bray GA. Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate. Am J Physiol Regul Integr Comp Physiol 277: R802-R811, 1999.
38. Smith GP, Jerome C, Cusin BJ, Eterno R, and Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037, 1981.
39. Sörhede M, Erlanson-Albertsson C, Mei J, Nevalainen T, Aho A, and Sundler F. Enterostatin in gut endocrine cells immunocytochemical evidence. Peptides 17: 609-614, 1996.
40. Tarasova NI, Stauber RH, Choi JK, Hudson EA, Czerwinski G, Miller JL, Pavlakis GN, Michejda CJ, and Wank SA. Visualization of G protein-coupled receptor trafficking with the aid of green fluorescent protein. J Biol Chem 272: 14817-14824, 1997.
41. Telegdy G, Kadar T, Kovacs K, and Penke B. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments. Life Sci 35: 163-170, 1984.
42. Tian Q, Nagase H, York DA, and Bray GA. Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin. Obesity Res 2: 527-534, 1994.
43. Vanderweele DA, Deems DA, and Gibbs J. Cholecystokinin, lithium, and diet self-selection in the rat: lithium chloride decreases protein, while cholecystokinin lowers fat and carbohydrate ingestion. Nutr Behav 2: 127-135, 1984.
44. West DB, Greenwood MRC, Marshall KA, and Woods SC. Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite 8: 221-227, 1987.
45. White CL, Bray GA, and York DA. Intragastric β-casomorphin attenuates the suppression of fat intake by enterostatin. Peptides 21: 1377-1381, 2000.
46. Wu YJ, Hughes D, Lin L, Braymer DH, and York DA. Comparative study of enterostatin sequence in five rat strains and enterostatin binding proteins in rat and chicken serum. Peptides 23: 537-544, 2002.
47. York DA and Lin L. Enterostatin and fat intake: current insights into possible mechanisms. In: Progress in Obesity Research, edited by Angel A, Anderson H, and Bouchard C. London: Libbey, 1996, p. 495-501.
48. York DA, Lin L, Smith B, and Chen J. Enterostatin as a regulator of fat intake. In: Neutral and Metabolic Control of Macronutrient Intake, edited by Berthoud H and Seeley R. Boca Raton, FL: CRC, 2000, chapt. 20, p. 295-308.